BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2870353)

  • 1. Double-blind, placebo-controlled study of luteinising-hormone-releasing-hormone nasal spray in treatment of undescended testes.
    deMuinck Keizer-Schrama SM; Hazebroek FW; Matroos AW; Drop SL; Molenaar JC; Visser HK
    Lancet; 1986 Apr; 1(8486):876-80. PubMed ID: 2870353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LH-RH nasal spray treatment for cryptorchidism. A double-blind, placebo-controlled study.
    De Muinck Keizer-Schrama SM; Hazebroek FW; Drop SL; Molenaar JC; Visser HK
    Eur J Pediatr; 1987; 146 Suppl 2():S35-7. PubMed ID: 2891518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Undescended testis treated by intranasal application of luteinizing hormone-releasing hormone (LH-RH)].
    Rasmussen TB; Kristensen ES; Gandrup P; Ingerslev HJ
    Ugeskr Laeger; 1991 Feb; 153(9):640-3. PubMed ID: 1672569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal therapy of cryptorchidism. A randomized, double-blind study comparing human chorionic gonadotropin and gonadotropin-releasing hormone.
    Rajfer J; Handelsman DJ; Swerdloff RS; Hurwitz R; Kaplan H; Vandergast T; Ehrlich RM
    N Engl J Med; 1986 Feb; 314(8):466-70. PubMed ID: 2868413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of the non-descended testis: doubtful value of luteinizing-hormone-releasing-hormone (LHRH). A double-blind, placebo-controlled multicentre study.
    Olsen LH; Genster HG; Mosegaard A; Jørgensen FS; Hofman N; Jensen VB; Lassen LB; Rassmussen M; Vinzents L; Dammegaard L
    Int J Androl; 1992 Apr; 15(2):135-43. PubMed ID: 1349301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary gonadotropin releasing hormone and adjunctive human chorionic gonadotropin treatment in cryptorchidism: a clinical trial.
    Nane I; Ziylan O; Esen T; Kocak T; Ander H; Tellaloglu S
    Urology; 1997 Jan; 49(1):108-11. PubMed ID: 9000196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luteinising hormone-releasing hormone nasal spray as therapy for undescended testicle.
    Pirazzoli P; Zappulla F; Bernardi F; Villa MP; Aleksandrowicz D; Scandola A; Stancari P; Cicognani A; Cacciari E
    Arch Dis Child; 1978 Mar; 53(3):235-8. PubMed ID: 25629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Success and relapse rate after treatment of cryptorchidism with intranasal LHRH.
    Schwarz HP; Aebi S; Perisic M
    Acta Paediatr Scand; 1985 Mar; 74(2):274-80. PubMed ID: 2859731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luteinising hormone releasing hormone for incomplete descent of the testis.
    Klidjian AM; Swift PG; Johnstone JM
    Arch Dis Child; 1985 Jun; 60(6):568-71. PubMed ID: 2861791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Success, relapse and failure after intranasal LHRH treatment of cryptorchidism in 55 prepubertal boys.
    Illig R; Bucher H; Prader A
    Eur J Pediatr; 1980 Mar; 133(2):147-50. PubMed ID: 6102517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of cryptorchidism with human chorionic gonadotropin or gonadotropin releasing hormone. A double-blind controlled study of 243 boys.
    Christiansen P; Müller J; Buhl S; Hansen OR; Hobolth N; Jacobsen BB; Jørgensen PH; Kastrup KW; Nielsen K; Nielsen LB
    Horm Res; 1988; 30(4-5):187-92. PubMed ID: 2907896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined therapy with LHRH and HCG in cryptorchid infants.
    Lala R; Matarazzo P; Chiabotto P; de Sanctis C; Canavese F; Hadziselimovic F
    Eur J Pediatr; 1993; 152 Suppl 2():S31-3. PubMed ID: 8101810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of cryptorchidism by intranasal synthetic luteinising-hormone releasing hormone. Results of a collaborative double-blind study.
    Illig R; Exner GU; Kollmann F; Kellerer K; Borkenstein M; Lunglmayr L; Kuber W; Prader A
    Lancet; 1977 Sep; 2(8037):518-20. PubMed ID: 95729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal treatment of cryptorchidism--hCG or GnRH--a multicentre study.
    Christiansen P; Müller J; Buhl S; Hansen OR; Hobolth N; Jacobsen BB; Jørgensen PH; Kastrup KW; Nielsen K; Nielsen LB
    Acta Paediatr; 1992 Aug; 81(8):605-8. PubMed ID: 1356527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of LHRH treatment on testicular descent and hormonal response in cryptorchidism.
    Wit JM; Delemarre-Van de Waal HA; Bax NM; Van den Brande JL
    Clin Endocrinol (Oxf); 1986 May; 24(5):539-48. PubMed ID: 2878745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of gonadoliberin administered nasally in cryptorchidism in aged 1 to 6].
    Job JC; Joab N; Safar A; Canlorbe P
    Arch Fr Pediatr; 1987 Feb; 44(2):91-5. PubMed ID: 2883952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early hormonal and surgical treatment of cryptorchidism.
    Lala R; Matarazzo P; Chiabotto P; Gennari F; Cortese MG; Canavese F; de Sanctis C
    J Urol; 1997 May; 157(5):1898-901. PubMed ID: 9112559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intranasal LHRH therapy on plasma LH, FSH and testosterone, and relation to clinical results in prepubertal boys with cryptorchidism.
    Illig R; Torresani T; Bucher H; Zachmann M; Prader A
    Clin Endocrinol (Oxf); 1980 Jan; 12(1):91-7. PubMed ID: 6103766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [LH-RH nasal spray (Kryptocur), a new aspect in the hormonal treatment of undescended testes (author's transl)].
    Zabransky S
    Klin Padiatr; 1981 Sep; 193(5):382-4. PubMed ID: 6116818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The medical treatment of cryptorchism in early childhood].
    Lala R; Canavese F; Matarazzo P; Chiabotto P; De Sanctis C
    Pediatr Med Chir; 1991; 13(1):73-5. PubMed ID: 1675784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.